Surgeons identify rates of C. difficile infection in patients undergoing common colon operations

Clostridium difficile infection is the most common hospital-acquired infection and a significant cause of increased hospital stay and cost for patients and payors alike. In the May issue of Diseases of the Colon & Rectum, surgeons from George Washington University Hospital sought to identify rates of C. difficile infection in patients undergoing common types of colon operations. These included both elective colon resection as well as closure of temporary stomas. In order to do this, the authors utilized the American College of Surgeons National Surgical Quality Improvement Project (ACS-NSQIP) and targeted colectomy database for 2015. They identified over 2200 patients who had undergone elective stoma reversal and over 10,000 patients who had undergone elective colon resection. Patients undergoing stoma reversal had a significantly higher rate of C. difficile infection in the first 30 postoperative day period than those undergoing colon resection (3.04% versus 1.25%, respectively). The authors identified that stoma reversal, smoking, steroid use, and disseminated cancer were all associated with a higher rate of postoperative C. difficile infection.

Author Matthew Skancke said: "We believe that our data presents compelling evidence of the increased incidence of postoperative Clostridium difficile in patients following ileostomy or colostomy reversal."​


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Therapeutic potential of human umbilical cord-derived mesenchymal stem cells in Crohn’s disease